Pfizer, Embrel, and Alzheimer’s
I’m getting my medical news from the front page of The Washington Post where Christopher Rowland discusses the possiblity that embrel, an anti arthritis drug, reduces the risk of Alzheimer’s dementia. The issue is clearly incredibly important. The article raises interesting ethical, economic, statistical, and biological questions. Better to click the link, but I will […]